Skip to main content
SpringerLink
Log in

Brain Tumors

  • Chapter
Neurosurgery

Part of the book series: European Manual of Medicine ((EUROMANUAL))

  • 6101 Accesses

Abstract

The classification of brain tumors has had a long history. Both general pathology and neurosurgery have influenced the description and classification of tumors of the nervous system. Whereas neurosurgery attempts to “classify” tumors for practical reasons, pathology offer general rules for doing so. Early attempts were made on the histogenetic level due to the collaboration between Percival Bailey and Harvey Cushing, but the emphasis was soon changed to the outcome of the patients. Thus, the prognosis has been one of the leading viewpoints of classification since the beginning [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

Selected Reading of Section 3.2.1

  1. Mennel HD (1993) Einteilungsprinzip intrakranieller Tumoren. Eine unbedingte Voraussetzung zur Therapie. TW Neurol Psychiatr 7:320–335

    Google Scholar 

  2. Kernohan JW, Mabon RF, Svien HJ, Adson AW (1949) A simplified classification of the gliomas. Symposium on a new simplified concept of gliomas. Proc Staff Meet Mayo Clin 24:71–75

    Google Scholar 

  3. Ringertz N (1950) Grading of gliomas. Acta Pathol Microbiol Scand 27:51–64

    CAS  PubMed  Google Scholar 

  4. Zülch KJ, Wechsler W (1968) Pathology and classification of gliomas. Prog Neurol Surg 2:1–84

    Google Scholar 

  5. Zülch KJ (1979) Histological typing of brain tumors. WHO, Geneva

    Google Scholar 

  6. Kleihues P, Burger PC, Scheithauer BW (eds) (1993) Histological typing of tumors of the central nervous system. Springer, Berlin Heidelberg New York

    Google Scholar 

  7. Kleihues P, Cavenee WK (eds) (2000) Pathology and genetics tumors of the nervous system. IARC, Lyons

    Google Scholar 

  8. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO Classification of Tumours of the Central Nervous System. IARC, Lyon+

    Google Scholar 

  9. Mennel HD (1988) Geschwülste des zentralen und peripheren Nervensystems. In: Doerr W, Seifert G (eds) Spezielle pathologische Anatomie, vol 13/III. Pathologie des Nervensystems III, pp 215–542

    Google Scholar 

  10. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357–363

    CAS  PubMed  Google Scholar 

  11. Ohgaki H, Reifenberger G, Nomura K, Kleihues P (2001) Gliomas. In: Gospodarowicz MK, Henson DE, Hutter RVP, O’Sullivan B, Sobin LH, Wittekind C (eds) Prognostic factors in cancer, 2nd edn. Wiley-Liss, New York, pp 725–743

    Google Scholar 

  12. Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE, Bishop JM (1984) Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 81:4940–4944

    CAS  PubMed  Google Scholar 

  13. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller, M, Kroos JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from telozolomide in glioblastoma. N Engl J Med 352:997–1003

    CAS  PubMed  Google Scholar 

  14. Zülch KJ (1975) Atlas of gross neurosurgical pathology. Springer, Berlin Heidelberg New York

    Google Scholar 

  15. Krauseneck P (1998) Neuroonkologie. Akt Neurol 25:219–226

    Google Scholar 

  16. Zülch KJ (1986) Brain tumors their biology and pathology. Springer, Berlin Heidelberg New York

    Google Scholar 

  17. Mennel HD, Plate KH (1991) Morphologie und Prognose bei intrakraniellen Tumoren. Fortschr Neurol Psychiatr 59:35–42

    CAS  PubMed  Google Scholar 

  18. Kleihues P, Ohgaki H (1999) Primary and secondary glioblastoma: from concept to clinical diagnosis. Neurooncology 1:44–51

    CAS  Google Scholar 

  19. Zankl H, Zang KD (1972) Cytological and cytogenetic studies on brain tumors. 4. Identification of the missing G chromosome in human meningiomas as no 22 by fluorescence techniques. Humangenetik 14:167–169

    CAS  PubMed  Google Scholar 

  20. Lekanne D, Bianchi AB, Groen NA, Warringa UL, Seizinger BR, Hagemeier A, van Drunen E, Bootsma D, Koper JW, Avezaat CJ, Kley N (1994) Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022–1029

    Google Scholar 

  21. Scherer HJ (1940) Cerebral astrocytomas and their derivatives. Am J Cancer 40:159–198

    Google Scholar 

  22. Tohma Y, Gratas C, Van Meir EG, Desbaillets I, Tenan M, Tachibana O, Kleihues P, Ohgaki H (1998) Necrogenesis and Fas/APO-1(CD95) expression in primary (de novo) and secondary glioblastoma. J Neuropathol Exp Neurol 57:239–245

    CAS  PubMed  Google Scholar 

  23. Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, Petersen I, Holl T, Wiestler OD, Kleihues P (1993) Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 8:74–80

    CAS  PubMed  Google Scholar 

  24. Cairncross JG, Laperiere NJ (1989) Low grade glioma. To treat or not to treat? Arch Neurol 46:1238–1239

    CAS  PubMed  Google Scholar 

  25. Peraud A, Watanabe K, Schwechheimer K, Yonekawa K, Kleihues P, Ohgaki H (1999) Genetic profile of the giant cell glioblastoma. Lab Invest 79:123–129

    CAS  PubMed  Google Scholar 

  26. Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59:520–529

    CAS  PubMed  Google Scholar 

  27. Biernat W, Agguzzi A, Sure U, Grant JW, Kleihues P, Hegi ME (1995) Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol 54:651–656

    CAS  PubMed  Google Scholar 

  28. Kepes JJ, Rubinstein LJ, Eng LF (1979) Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis; a study of 12 cases. Cancer 44:1839–1852

    CAS  PubMed  Google Scholar 

  29. Scheinker IM (1945) Subependymoma: a newly recognized tumor of subependymal derivation. J Neurosurg 2:232–240

    Google Scholar 

  30. Fletcher CDM, Unni KK, Mertens F (eds) (2002) WHO classification of tumours: pathology and genetics of soft tissues and bone. IARC, Lyon

    Google Scholar 

  31. Hassoun J, Gambarelli D, Grisoli F, Pellet W, Salamon G, Pellisier JF, Toga M (1982) Central neurocytoma. An electron microscopic study of two cases. Acta Neuropathol (Berl) 56:151–156

    CAS  Google Scholar 

  32. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C (1988) Dysembryoblastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty nine cases. Neurosurgery 23:545–556

    CAS  PubMed  Google Scholar 

Selected Reading of Section 3.2.2

  1. Adami H, Hunter D, Trichopoulos D (2002). Textbook of cancer epidemiology. Oxford University Press, Oxford

    Google Scholar 

  2. Cassidy J, Bissett D, Spence RAJ (eds) (2006) Oxford handbook of oncology, 2nd edn, Oxford University Press, Oxford

    Google Scholar 

  3. Dreifaldt AC, Carlberg M, Hardell L (2004) Increasing incidence rates of childhood malignant diseases in Sweden during the period 1960–1998. Eur J Cancer 40:1351–1360

    PubMed  Google Scholar 

  4. Engels EA, Katki H, Nielsen NM, Winther JF, Hjalgrim H, Gjerris F, Rosenberg PS, Frisch M (2003) Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Nat Cancer Inst 95:532–539

    CAS  PubMed  Google Scholar 

  5. Gjerris F, Harmsen A, Klinken L, Reske-Nielsen E (1978) Incidence and long-term survival of children with intracranial tumours treated in Denmark 1935–1959. Brit J Cancer 38:442–451

    CAS  PubMed  Google Scholar 

  6. Gjerris F, Agerlin N, Buhl L, Børgesen SE, Haase J, Johansen H, Klinken L, Mortensen AC, Møller C, Ovesen N, Reske-Nielsen E, Schmidt K (1998) Epidemiology and prognosis of intracranial tumours in children in Denmark 1960–84. Childs Nerv Syst 14:302–311

    CAS  PubMed  Google Scholar 

  7. Hebel JR, McCarter RJ (2006) A study guide to epidemiology and biostatistics. James and Bartlett, Boston

    Google Scholar 

  8. http://info.cancerresearchuk.org/cancerstats/types/brain

    Google Scholar 

  9. Jellinger K (1987) Pathology of human intracranial neoplasia. In: Jellinger K (ed) Therapy of malignant brain tumours. Springer, Vienna

    Google Scholar 

  10. Kaatsch P, Rickert CH, Kuhl J, Schuz J, Michaelis J (2001) Population-based epidemiologic data on brain tumours in German children. Cancer 92:3155–3164

    CAS  PubMed  Google Scholar 

  11. Lannering B, Marky I, Nordborg C (1990) Brain tumors in childhood and adolescence in west Sweden 1970–1984. Epidemiology and survival. Cancer 66:604–609

    CAS  PubMed  Google Scholar 

  12. Lilienfeld DW, Stolley PD (1994) Foundations of epidemiology, 3rd edn. Oxford University Press, New York

    Google Scholar 

  13. Merrill RM, Timmreck TC (2004) Introduction to epidemiology, 4th edn. James and Bartlett, Boston

    Google Scholar 

  14. Muir C, Waterhouse J, Mack T, Powell J, Whelan S (1987) Cancer incidence in five continents, vol V. IARC Scientific Publications No. 88. International Agency for Research on Cancer, Lyon

    Google Scholar 

  15. Office for National Statistics (2006) Cancer statistics registrations: Registrations of cancer diagnosed in 2003, England. Series MB1 no.34. 2006. National Statistics, London

    Google Scholar 

  16. Oleckno WA (2002) Essential epidemiology: principles and application. Waveland Press, Long Grove

    Google Scholar 

  17. Raaschou-Nielsen O, Sørensen M, Carstensen H, Jensen T, Bernhardtsen T, Gjerris F, Schmiegelow K (2006) Increasing incidence of childhood tumours of the central nervous system in Denmark 1980–1996. Br J Cancer 95:416–422

    CAS  PubMed  Google Scholar 

  18. Rochat P, Johansen HH, Gjerris F (2004) Long-term follow-up of children with meningiomas in Denmark 1935–84. J Neurosurg (Pediatrics) 100:179–182

    Google Scholar 

  19. Rothman KJ, Greeland S (1998) Modern epidemiology, 2nd edn. Lippincott-Raven, Philadelphia

    Google Scholar 

  20. Szklo M, Nieto FJ (2004) Epidemiology, beyond the basis. James and Bartlett, Boston

    Google Scholar 

  21. Viscomi S, Pastore G, Mosso ML, Terracini B, Madon E, Magnani C, Merletti F (2003) Population-based survival after childhood cancer diagnosed during 1970–98: a report from the Childhood Cancer Registry of Piedmont, Italy. Haematologica 88:974–982

    PubMed  Google Scholar 

Selected Reading of Section 3.2.4

  1. Bailey P, Stein SN (1951) A stereotactic apparatus for use on the human brain. AMA scientific exhibit, Atlantic City

    Google Scholar 

  2. Bernstein M, Parrent AG (1994) Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81:165–168

    CAS  PubMed  Google Scholar 

  3. Bittar RG, Olivier A, Sadikot AF, Andermann F, Pike GB, Reutens DC (1999) Presurgical motor and somatosensory cortex mapping with functional magnetic resonance imaging and positron emission tomography. J Neurosurg 91(6):915–921

    CAS  PubMed  Google Scholar 

  4. Blaauw G, Braakman R (1988) Pitfalls in diagnostic brain surgery. Acta Neurochir (Wien) Suppl 42:161–165

    CAS  Google Scholar 

  5. Brown RA, Roberts TS, Osborn AG (1980) Stereotactic frame and computer software for CT-directed neurosurgical localization. Invest Radiol 15:308–312

    CAS  PubMed  Google Scholar 

  6. Cook RJ, Guthrie BL (1993) Complications of stereotactic biopsy. Perspect Neurol Surg 4:131–140

    Google Scholar 

  7. Gildenberg PL (1988) General concept of stereotactic surgery. In Lunsford LD (ed) Modern stereotactic neurosurgery. Oston Martinus Nijhoff, pp 3–12

    Google Scholar 

  8. Hara T, Kondo T, Hara T, Kosaka N (2003) Use of 18F-choline and 11C-cholin as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 99:474–479

    PubMed  Google Scholar 

  9. Hecaen H, Thalairach T, David M, Dell MB (1949) Memoires originaux: Coagulation limiteses du thalamus dans les algies du syndrome thalamique. Rev Neurol (Paris) 81: 917–931

    Google Scholar 

  10. Horsley V; Clarke RH (1908) The structure and the function of the cerebellum examined by a new method. Brain 31:45

    Google Scholar 

  11. Hounsfield GN, Ambrose J, Perry BJ, Bridges C (1973) Computerized transverse axial scanning (tomography). Br J Radiol 46:1016–1051

    CAS  PubMed  Google Scholar 

  12. Kelly PJ (1991) Tumor stereotaxis. Saunders, Philadelphia, pp 183–223

    Google Scholar 

  13. Kleihues P, Volk B, Anagnostopoulos J, Kiessling M (1984) Morphologic evaluation of stereotactic brain tumour biopsies. Acta Neurochir (Wien) Suppl 33:171–181

    CAS  Google Scholar 

  14. Leksell L (1949) A stereotactic apparatus for intracranial surgery. Acta Chir Scand 99:229–233

    Google Scholar 

  15. Leksell L (1971) Stereotaxis and radiosurgery: an operative system. Thomas, Springfield

    Google Scholar 

  16. Mosskin M, Ericson K, Hindmarsh T, von Holst H, Collins VP, Bergstrom M, Eriksson L, Johnstrom P (1989) Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 30(3):225–232

    CAS  PubMed  Google Scholar 

  17. Mundinger F (1985) CT-stereotactic biopsy of intracranial processes. Acta Neurochir (Wien) Suppl 35:70–74

    CAS  Google Scholar 

  18. Narabayashi H (1952) Stereotactic instrument for operation on the human basal ganglia. Psychiatr Neurol Jpn 54:669–671

    Google Scholar 

  19. Riechert T, Wolff M (1951) Über ein neues Zielgerät zur intrakraniellen elektrischen Ableitung und Ausschaltung. Arch Psychiatr Z Neurol 186:225–230

    CAS  Google Scholar 

  20. Spiegel EA, Wycis HT (1950) Pallido-thalamothomy in chorea. Arch Neurol Psychiatr 64:495–496

    Google Scholar 

  21. Spiegel EA, Wycis HT (1952) Stereoencephalotomy. I. Grune & Stratton, New York

    Google Scholar 

  22. Spiegel EA, Wycis HT, Marks M, Lee AJ (1947) Stereotaxic apparatus for operations on the human brain. Science 106:349–350

    PubMed  CAS  Google Scholar 

  23. Talairach J, David M, Tournoux P, Corredor H, Kvasina T (1957) Atlas d’anatomie Stèrèotaxique. Repérage radiologique indirect des noyaux gris centraux des regions mésencéphalo-sous-optique et hypothalamique de l’homme. Masson et Cie, Paris

    Google Scholar 

  24. Thomas DGT, Nouby RM (1989) Experience in 300 cases of CT-directed stereotactic surgery for lesion biopsy and aspiration of haematoma. Br J Neurosurg 3:321–326

    CAS  PubMed  Google Scholar 

  25. Ungersböck K, Schmidbauer M, Budka H, Kitz K, Grunert P, Koos W (1989) Stereotaktische Biopsie intrakranieller Prozesse: Validität der histologischen Diagnostik. Wien Klein Wochenschr 101:376–380

    Google Scholar 

  26. Voges J, Schröder R, Treuer H, Pastyr O, Schlegel W, Lorenz WJ, Sturm V (1993) CT-guided and computer assisted stereotactic biopsy: technique, results, indications. Acta Neurochir (Wien) 125:142–149

    CAS  Google Scholar 

  27. Zernov DN (1889) Encephalometer: device for estimation of parts of brain in human. Proc Soc Physiomed Moscow Univ 2:70–80

    Google Scholar 

Selected Reading of Section 3.2.5.1

  1. CBTRUS (2004) Statistical report: primary brain tumors in the United States, 1997–2001. Central Brain Tumor Registry in the United States

    Google Scholar 

  2. Grossman SA, Batara JF (2004) Current management of glioblastoma multiforme. Semin Oncol 31:635–644

    CAS  PubMed  Google Scholar 

  3. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003

    CAS  PubMed  Google Scholar 

  4. Hildebrand J (2004) Management of epileptic seizures. Curr Opin Oncol 16:314–317

    PubMed  Google Scholar 

  5. Jeuken JW, Sprenger SH, Boerman RH, von Deimling A, Teepen HL, van Overbeeke JJ, Wesseling P (2001) Subtyping of oligo-astrocytic tumours by comparative genomic hybridization. J Pathol 194:81–87

    CAS  PubMed  Google Scholar 

  6. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225; discussion 226–219

    Google Scholar 

  7. Kondziolka D, Lunsford LD (1999) The role of stereotactic biopsy in the management of gliomas. J Neurooncol 42:205–213

    CAS  PubMed  Google Scholar 

  8. Law M, Hamburger M, Johnson G, Inglese M, Londono A, Golfinos J, Zagzag D, Knopp EA (2004) Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging. Technol Cancer Res Treat 3:557–565

    PubMed  Google Scholar 

  9. Laws ER, Shaffrey ME, Morris A, Anderson FA Jr (2003) Surgical management of intracranial gliomas – does radical resection improve outcome? Acta Neurochir Suppl 85:47–53

    CAS  PubMed  Google Scholar 

  10. Piepmeier J, Baehring JM (2004) Surgical resection for patients with benign primary brain tumors and low grade gliomas. J Neurooncol 69:55–65

    PubMed  Google Scholar 

  11. Schramm J, Luyken C, Urbach H, Fimmers R, Blumcke I (2004) Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy. Neurosurgery 55:340–347; discussion 347–348

    Google Scholar 

  12. a. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rhode V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T, ALA-Glioma Study Group (2008) Extent of resection and survival in glioblastoma multiforme: identification of an adjustment for bias. Neurosurgery 62(3):564–576

    Google Scholar 

  13. Stummer W, Reulen HJ, Novotny A, Stepp H, Tonn JC (2003) Fluorescence-guided resections of malignant gliomas – an overview. Acta Neurochir Suppl 88:9–12

    CAS  PubMed  Google Scholar 

  14. Stupp R, van den Bent MJ, Hegi ME (2005) Optimal role of temozolomide in the treatment of malignant gliomas. Curr Neurol Neurosci Rep 5:198–206

    CAS  PubMed  Google Scholar 

  15. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neurooncology 5:79–88

    CAS  Google Scholar 

  16. Westphal M, Ekman M, Andlin-Sobocki P, Lönn S, Heese O (2009) Brain tumor epidemiology in the European Union: a critical assessment. Acta Neurochir, in revision.

    Google Scholar 

  17. Wiestler OD, Schiffer D, Coons S, Prayson RA, Rosenblum MK (2000) Ependymoma. In: Kleihues P, Cavanee W (eds) Tumours of the nervous system: pathology and genetics. IARC, Lyon

    Google Scholar 

  18. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neurooncology 4:278–299

    Google Scholar 

Selected Reading of Section 3.2.5.2

  1. Al-Mefti O (1991) Meningiomas. Raven, New York

    Google Scholar 

  2. Al-Mefti O (1998) Operative atlas of meningioma. Lippincott-Raven, Philadelphia

    Google Scholar 

  3. Beaumont A, Whittle IR (2000) The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) 142:1–15

    CAS  Google Scholar 

  4. Becker G, Jeremic B, Pitz S, Buchgeister M, Wilhelm H, Schiefer U, Paulsen F, Zrenner E, Bamberg M (2002) Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 54:1422–1429

    PubMed  Google Scholar 

  5. Bendszus M, Rao G, Burger R, Schaller C, Scheinemann K, Warmuth-Metz M, Hofmann E, Schramm J, Roosen K, Solymosi L (2000) Is there a benefit of preoperative meningioma embolization? Neurosurgery 47:1306–1311; discussion 1311–1302

    Google Scholar 

  6. Brock M (2005) The heroes return to earth. Surg Neurol 63:590–591

    PubMed  Google Scholar 

  7. Buhl R, Hugo HH, Mehdorn HM (Brain oedema in secretory meningiomas. J Clin Neurosci 8 [Suppl 1]:19–21

    Google Scholar 

  8. Bull WJ, Vandevender D, Cimino VG (2003) Reconstruction of defects of the cranial base. Tech Neurosurg 9:106–112

    Google Scholar 

  9. Chamberlain MC, Blumenthal DT (2004) Intracranial meningiomas: diagnosis and treatment. Expert Rev Neurother 4:641–648

    PubMed  Google Scholar 

  10. Chamberlain MC, Tsao-Wei DD, Groshen S (2004) Temozolomide for treatment-resistant recurrent meningioma. Neurology 62:1210–1212

    CAS  PubMed  Google Scholar 

  11. Fountas KN, Kapsalaki EZ, Gotsis SD, Kapsalakis JZ, Smisson HF III, Johnston KW, Robinson JS Jr, Papadakis N (2000) In vivo proton magnetic resonance spectroscopy of brain tumors. Stereotact Funct Neurosurg 74:83–94

    CAS  PubMed  Google Scholar 

  12. Grunberg SM (1994) Role of antiprogestational therapy for meningiomas. Hum Reprod 9 [Suppl 1]:202–207

    PubMed  Google Scholar 

  13. Hart DJ, Gianotta SL (2003) Complex cranial base meningioma: combined management. Tech Neurosurg 9:86–92

    Google Scholar 

  14. Hemminki K, Li X (2003) Familial risks in nervous system tumors. Cancer Epidemiol Biomarkers Prev 12:1137–1142

    PubMed  Google Scholar 

  15. Jääskeläinen J, Louis DN, Paulus W, Haltia M (2000) Haemangiopericytoma. In: Kleihues P, Cavanee WK (eds) Tumors of the central nervous system: pathology and genetics. IARC, Lyon

    Google Scholar 

  16. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99:848–853

    CAS  PubMed  Google Scholar 

  17. Kaminski JM, Movsas B, King E, Yang C, Kronz JD, Alli PM, Williams J, Brem H (2001) Metastatic meningioma to the lung with multiple pleural metastases. Am J Clin Oncol 24:579–582

    CAS  PubMed  Google Scholar 

  18. Kondziolka D, Nathoo N, Flickinger JC, Niranjan A, Maitz AH, Lunsford LD (2003) Long-term results after radiosurgery for benign intracranial tumors. Neurosurgery 53:815–821; discussion 821–812

    Google Scholar 

  19. Kremer S, Grand S, Remy C, Pasquier B, Benabid AL, Bracard S, Le Bas JF (2004) Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology 46:642–648

    CAS  PubMed  Google Scholar 

  20. Kyritsis AP (1996) Chemotherapy for meningiomas. J Neurooncol 29:269–272

    CAS  PubMed  Google Scholar 

  21. Laidlaw JD, Kumar A, Chan A (2004) Dural metastases mimicking meningioma. Case report and review of the literature. J Clin Neurosci 11:780–783

    PubMed  Google Scholar 

  22. Lamszus K (2004) Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63:275–286

    PubMed  Google Scholar 

  23. Lamszus K, Vahldiek F, Mautner VF, Schichor C, Tonn J, Stavrou D, Fillbrandt R, Westphal M, Kluwe L (2000) Allelic losses in neurofibromatosis 2-associated meningiomas. J Neuropathol Exp Neurol 59:504–512

    CAS  PubMed  Google Scholar 

  24. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavanee WK (eds) Tumours of the nervous system : pathology and genetics. IARC, Lyon

    Google Scholar 

  25. Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH, Fenig E, Ram Z, Sulkes A (2004) Non-resectable slow-growing meningiomas treated by hydroxyurea. J Neurooncol 67:221–226

    PubMed  Google Scholar 

  26. Mason WP, Gentili F, Macdonald DR, Hariharan S, Cruz CR, Abrey LE (2002) Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg 97:341–346

    CAS  PubMed  Google Scholar 

  27. Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538–550; discussion 538–550

    Google Scholar 

  28. Probst EN, Grzyska U, Westphal M, Zeumer H (1999) Preoperative embolization of intracranial meningiomas with a fibrin glue preparation. AJNR Am J Neuroradiol 20:1695–1702

    CAS  PubMed  Google Scholar 

  29. Rosen CL, Ammerman JM, Sekhar LN, Bank WO (2002) Outcome analysis of preoperative embolization in cranial base surgery. Acta Neurochir (Wien) 144:1157–1164

    CAS  Google Scholar 

  30. Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D (2002) Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg 97:1078–1082

    PubMed  Google Scholar 

  31. Sijens PE, Oudkerk M (2002) Diagnosing dural metastases. Neuroradiology 44:275; author reply 276

    PubMed  Google Scholar 

  32. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–29

    CAS  PubMed  Google Scholar 

  33. Stark AM, Mehdorn HM (2004) Images in neuro-oncology: dural metastases. J Neurooncol 68:11

    PubMed  Google Scholar 

  34. Swensen R, Kirsch W (2002) Brain neoplasms in women: a review. Clin Obstet Gynecol 45:904–927

    PubMed  Google Scholar 

  35. Tagle P, Villanueva P, Torrealba G, Huete I (2002) Intracranial metastasis or meningioma? An uncommon clinical diagnostic dilemma. Surg Neurol 58:241–245

    PubMed  Google Scholar 

  36. Tonn JC (2004) Microneurosurgery and radiosurgery – an attractive combination. Acta Neurochir Suppl 91:103–108

    CAS  PubMed  Google Scholar 

  37. Wahab M, Al-Azzawi F (2003) Meningioma and hormonal influences. Climacteric 6:285–292

    CAS  PubMed  Google Scholar 

  38. Wan WL, Geller JL, Feldon SE, Sadun AA (1990) Visual loss caused by rapidly progressive intracranial meningiomas during pregnancy. Ophthalmology 97:18–21

    CAS  PubMed  Google Scholar 

Selected Reading of Section 3.2.5.3

  1. Bellinzona M, Roser F, Ostertag H, Gaab RM, Saini M (2005) Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases. Eur J Surg Oncol 31:100–105

    CAS  PubMed  Google Scholar 

  2. Castellano-Sanchez AA, Li S, Qian J, Lagoo A, Weir E, Brat DJ (2004) Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 121:246–253

    PubMed  Google Scholar 

  3. DeAngelis LM (2003) Primary central nervous system lymphoma: a curable brain tumor. J Clin Oncol 21:4471–4473

    PubMed  Google Scholar 

  4. DeAngelis LM, Hormigo A (2004) Treatment of primary central nervous system lymphoma. Semin Oncol 31:684–692

    PubMed  Google Scholar 

  5. Fliessbach K, Helmstaedter C, Urbach H, Althaus A, Pels H, Linnebank M, Juergens A, Glasmacher A, Schmidt-Wolf IG, Klockgether T, Schlegel U (2005) Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology 64:1184–1188

    CAS  PubMed  Google Scholar 

  6. Kuker W, Nagele T, Korfel A, Heckl S, Thiel E, Bamberg M, Weller M, Herrlinger U (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 72:169–177

    PubMed  Google Scholar 

  7. Paulus W, Jellinger K, Morgello S, Deckert-Schlüter M (2000) Malignant lymphomas. In: Kleihues P, Cavanee W (eds) Pathology and genetics tumors of the nervous system. IARC, Lyon, pp 198–203

    Google Scholar 

  8. Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U (2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489–4495

    CAS  PubMed  Google Scholar 

  9. Shenkier TN, Blay JY, O’Neill BP, Poortmans P, Thiel E, Jahnke K, Abrey LE, Neuwelt E, Tsang R, Batchelor T, Harris N, Ferreri AJ, Ponzoni M, O’Brien P, Rubenstein J, Connors JM (2005) Primary CNS lymphoma of T-cell origin: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group. J Clin Oncol 23:2233–2239

    PubMed  Google Scholar 

  10. Soussain C, Hoang-Xuan K, Doolittle ND (2005) New treatment approaches in primary central nervous system lymphoma. Hematol Oncol Clin North Am 19:719–728, vii

    PubMed  Google Scholar 

  11. Warnke PC, Timmer J, Ostertag CB, Kopitzki K (2005) Capillary physiology and drug delivery in central nervous system lymphomas. Ann Neurol 57:136–139

    PubMed  Google Scholar 

Selected Reading of Section 3.2.5.4

  1. Altundag OO, Celik I, Kars A (2002) Pineal germ cell tumor metastasis via ventriculoperitoneal shunt. Am J Clin Oncol 25:104–105

    PubMed  Google Scholar 

  2. Bruce JN, Ogden AT (2004) Surgical strategies for treating patients with pineal region tumors. J Neurooncol 69:221–236

    PubMed  Google Scholar 

  3. Hasegawa T, Kondziolka D, Hadjipanayis CG, Flickinger JC, Lunsford LD (2003) Stereotactic radiosurgery for CNS nongerminomatous germ cell tumors. Report of four cases. Pediatr Neurosurg 38:329–333

    PubMed  Google Scholar 

  4. Herrmann HD, Winkler D, Westphal M (1992) Treatment of tumours of the pineal region and posterior part of the third ventricle. Acta Neurochir (Wien) 116:137–146

    CAS  Google Scholar 

  5. Herrmann HD, Westphal M, Winkler K, Laas RW, Schulte FJ (1994) Treatment of nongerminomatous germ-cell tumors of the pineal region. Neurosurgery 34:524–529; discussion 529

    CAS  PubMed  Google Scholar 

  6. Hooda BS, Finlay JL (1999) Recent advances in the diagnosis and treatment of central nervous system germ-cell tumours. Curr Opin Neurol 12:693–696

    CAS  PubMed  Google Scholar 

  7. Kaur H, Singh D, Peereboom DM (2003) Primary central nervous system germ cell tumors. Curr Treat Options Oncol 4:491–498

    PubMed  Google Scholar 

  8. Liang L, Korogi Y, Sugahara T, Ikushima I, Shigematsu Y, Okuda T, Takahashi M, Kochi M, Ushio Y (2002) MRI of intracranial germ-cell tumours. Neuroradiology 44:382–388

    CAS  PubMed  Google Scholar 

  9. Ogawa K, Shikama N, Toita T, Nakamura K, Uno T, Onishi H, Itami J, Kakinohana Y, Kinjo T, Yoshii Y, Ito H, Murayama S (2004) Long-term results of radiotherapy for intracranial germinoma: a multi-institutional retrospective review of 126 patients. Int J Radiat Oncol Biol Phys 58:705–713

    PubMed  Google Scholar 

  10. Reddy AT, Wellons JC III, Allen JC, Fiveash JB, Abdullatif H, Braune KW, Grabb PA (2004) Refining the staging evaluation of pineal region germinoma using neuroendoscopy and the presence of preoperative diabetes insipidus. Neurooncology 6:127–133

    Google Scholar 

  11. Rosenblum MK, Matsutani M, Van Meir EG (2000) CNS germ cell tumors. In: Kleihues P, Cavanee W (eds) Pathology and genetics of tumors of the nervous system. IARC, Lyon, pp 208–214

    Google Scholar 

  12. Saif MW, Takimoto CH (2003) Pineal germinoma followed by hematogenous metastases. South Med J 96:117–119

    PubMed  Google Scholar 

  13. Wellons JC III, Reddy AT, Tubbs RS, Abdullatif H, Oakes WJ, Blount JP, Grabb PA (2004) Neuroendoscopic findings in patients with intracranial germinomas correlating with diabetes insipidus. J Neurosurg 100:430–436

    PubMed  Google Scholar 

  14. Wong TT, Yen SH, Ho DM, Chang FC, Chang KP (2003) Pineal germinoma with intratumoral hemorrhage after neuroendoscopic tumor biopsy. Childs Nerv Syst 19:769–772

    PubMed  Google Scholar 

  15. Yurtseven T, Ersahin Y, Demirtas E, Mutluer S (2003) Neuroendoscopic biopsy for intraventricular tumors. Minim Invasive Neurosurg 46:293–299

    CAS  PubMed  Google Scholar 

Selected Reading of Section 3.2.5.5

  1. Couldwell WT (2004) Transsphenoidal and transcranial surgery for pituitary adenomas. J Neurooncol 69:237–256

    PubMed  Google Scholar 

  2. Couldwell WT, Weiss MH (2004) Medical and surgical management of microprolactinoma. Pituitary 7:31–32

    PubMed  Google Scholar 

  3. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237–250

    CAS  PubMed  Google Scholar 

  4. Flitsch J, Ludecke DK, Knappe UJ, Grzyska U (2002) Cavernous sinus sampling in selected cases of Cushing’s disease. Exp Clin Endocrinol Diabetes 110:329–335

    CAS  PubMed  Google Scholar 

  5. Janzer RC, Burger PC, Giangaspero F, Paulus W (2000) Craniopharyngioma. In: Kleihues P, Cavanee W (eds) Pathology and genetics of tumors of the central nervous system. IARC, Lyon

    Google Scholar 

  6. Kovacs K, Horvath E, Vidal S (2001) Classification of pituitary adenomas. J Neurooncol 54:121–127

    CAS  PubMed  Google Scholar 

  7. Kreutzer J, Fahlbusch R (2004) Diagnosis and treatment of pituitary tumors. Curr Opin Neurol 17:693–703

    PubMed  Google Scholar 

  8. Laws ER, Sheehan JP, Sheehan JM, Jagnathan J, Jane JA Jr, Oskouian R (2004) Stereotactic radiosurgery for pituitary adenomas: a review of the literature. J Neurooncol 69:257–272

    PubMed  Google Scholar 

  9. Leung GK, Lopes MB, Thorner MO, Vance ML, Laws ER Jr (2004) Primary hypophysitis: a single-center experience in 16 cases. J Neurosurg 101:262–271

    PubMed  Google Scholar 

  10. Ng WH, Gonzales M, Kaye AH (2003) Lymphocytic hypophysitis. J Clin Neurosci 10:409–413

    PubMed  Google Scholar 

  11. Pickett CA (2005) Update on the medical management of pituitary adenomas. Curr Neurol Neurosci Rep 5:178–185

    CAS  PubMed  Google Scholar 

  12. Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, Kendall-Taylor P, Mathias D, Perros P, Quinton R, Vaidya B (2004) Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 7:157–163

    PubMed  Google Scholar 

  13. Varlotto JM, Flickinger JC, Kondziolka D, Lunsford LD, Deutsch M (2002) External beam irradiation of craniopharyngiomas: long-term analysis of tumor control and morbidity. Int J Radiat Oncol Biol Phys 54:492–499

    PubMed  Google Scholar 

  14. Wara WM, Sneed PK, Larson DA (1994) The role of radiation therapy in the treatment of craniopharyngioma. Pediatr Neurosurg 21 [Suppl 1]:98–100

    PubMed  Google Scholar 

Selected Reading of Section 3.2.5.6

  1. Barker FG II (2005) Surgical and radiosurgical management of brain metastases. Surg Clin North Am 85:329–345

    PubMed  Google Scholar 

  2. Burton A (2004) High incidence of brain metastases with trastuzumab treatment. Lancet Oncol 5:523

    PubMed  Google Scholar 

  3. Kaal EC, Niel CG, Vecht CJ (2005) Therapeutic management of brain metastasis. Lancet Neurol 4:289–298

    PubMed  Google Scholar 

  4. Koc M, McGregor J, Grecula J, Bauer CJ, Gupta N, Gahbauer RA (2005) Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neurooncol 71:307–313

    PubMed  Google Scholar 

  5. Langer CJ, Mehta MP (2005) Current management of brain metastases, with a focus on systemic options. J Clin Oncol 23:6207–6219

    CAS  PubMed  Google Scholar 

  6. Paek SH, Audu PB, Sperling MR, Cho J, Andrews DW (2005) Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 56:1021–1034; discussion 1021–1034

    Google Scholar 

  7. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489

    CAS  PubMed  Google Scholar 

  8. Pollock BE, Brown PD, Foote RL, Stafford SL, Schomberg PJ (2003) Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol 61:73–80

    PubMed  Google Scholar 

  9. Shehata MK, Young B, Reid B, Patchell RA, St Clair W, Sims J, Sanders M, Meigooni A, Mohiuddin M, Regine WF (2004) Stereotactic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 59:87–93

    PubMed  Google Scholar 

  10. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD (2005) The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 62:1125–1132

    PubMed  Google Scholar 

  11. Vecil GG, Suki D, Maldaun MV, Lang FF, Sawaya R (2005) Resection of brain metastases previously treated with stereotactic radiosurgery. J Neurosurg 102:209–215

    PubMed  Google Scholar 

  12. Westphal M, Heese O, de Wit M (2003) Intracranial metastases: therapeutic options. Ann Oncol 14 [Suppl 3]:iii4–10

    Google Scholar 

Selected Reading of Section 3.2.6.3

  1. Anderson TD, Loevner LA, Bigelow DC, Mirza N (2000) Prevalence of unsuspected acoustic neuroma found by magnetic resonance imaging. Otolaryngol Head Neck Surg 122:643–646

    CAS  PubMed  Google Scholar 

  2. Fuentes S, Delsanti C, Metellus P, Peragut JC, Grisoli F, Regis J (2006) Brainstem metastases: management using gamma knife radiosurgery. Neurosurgery 58:37–42

    PubMed  Google Scholar 

  3. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003

    CAS  PubMed  Google Scholar 

  4. House J W, Brackmann D E (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:184–193

    Google Scholar 

  5. Kanner AA, Suh JH, Siomin VE, Lee SY, Barnett GH, Vogelbaum MA (2003) Posterior fossa metastases: aggressive treatment improves survival. Stereotact Funct Neurosurg 81:18–23

    PubMed  Google Scholar 

  6. Kleihues P, Cavenee WK (eds) (2000) Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer, Lyon

    Google Scholar 

  7. Koos WT, Day JD, Matula C, Levy DI (1998) Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg 88:506–512

    CAS  PubMed  Google Scholar 

  8. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum cultured cell lines. Cancer Cell 9:391–403

    CAS  PubMed  Google Scholar 

  9. Roberti F, Sekhar LN, Kalavakonda C, Wright DC (2001) Posterior fossa meningiomas: surgical experience in 161 cases. Surg Neurol 56:8–20

    CAS  PubMed  Google Scholar 

  10. Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, Aldape KD, Albin MG, Emnett RJ, Loeser S, Watson MA, Nagarajan R, Gutmann DH (2007) Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 67:890–900

    CAS  PubMed  Google Scholar 

Selected Reading of Section 3.2.6.4

  1. Bruneau M, Cornelius JF, George B (2005) Osteoid osteomas and osteoblastomas of the occipito-cervical junction. Spine 30:E567–571

    PubMed  Google Scholar 

  2. Bruneau M, Cornelius JF, George B (2006) Anterolateral approach to the V3 segment of the vertebral artery. Neurosurgery 58:29–35

    Google Scholar 

  3. Carpentier A, Polivka M, Blanquet A, George B (2002) Suboccipital and cervical chordomas. The value of aggressive treatment at first presentation. J Neurosurg 97:1070–1077

    PubMed  Google Scholar 

  4. Crockard HA, Johnston F (1993) Development of transoral approaches to lesions of the skull base and craniovertebral junction. Neurosurg Quart 3:61–82

    Google Scholar 

  5. George B, Carpentier A (2001) Compression of and by the vertebral artery. In: Spetzler R (ed) Operative techniques in neurosurgery, vol 4. Saunders, Orlando, pp 202–218

    Google Scholar 

  6. George B, Blanquet A, Alves O (2002) The V3 segment of the vertebral artery. Surgery around the craniocervical junction. In: Spetzler R (ed) Operative techniques in neurosurgery, vol 5. Saunders, Orlando, pp 50–74

    Google Scholar 

  7. George B (2002) Extracranial vertebral artery anatomy and surgery. In: Pickard JD (ed) Advances and technical standards in neurosurgery, vol 27. Springer, Vienna, pp 179–211

    Google Scholar 

  8. Menezes AH (1998) Embryology, development and classification of disorders of the craniovertebral junction. In: Dickmans CA, Spetlez RF, Sonttag VKH (eds) Surgery of the craniovertebral junction. Thieme, New York, pp 3–12

    Google Scholar 

  9. Menezes AH, Van Gilder JC, Graf CJ, McDonnell DE (1980) Craniocervical abnormalities. A comprehensive surgical approach. J Neurosurg 63:444–455

    Google Scholar 

Selected Reading of Section 3.2.7

  1. Christ WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruyman FB, Breneman J et al. (2001) Intergroup rhabdomyosarcoma study IV: results for patients with nonmetastatic disease. J Clin Oncol 19:3091–3102

    Google Scholar 

  2. De Jesús O, Toledo MM (2001) Surgical management of meningioma en plaque of the sphenoid ridge. Surg Neurol 55:265–269

    PubMed  Google Scholar 

  3. Gunalp I, Gunduz K (1995) Pediatric orbital tumors in Turkey. Ophthal Plast Reconstr Surg 11:193–199

    Article  CAS  PubMed  Google Scholar 

  4. Gunalp I, Gunduz K (1995) Vascular tumors of the orbit. Doc Ophthalmol 89:337–345

    CAS  PubMed  Google Scholar 

  5. Hassler WE, Eggert H (1985) Extradural and intradural microsurgical approaches to lesions of the optic canal and the superior orbital fissure. Acta Neurochir (Wien) 74:87–93

    CAS  Google Scholar 

  6. Hejazi N, Hassler W, Farghaly F (1999) Transconjunctival microsurgical approach to the orbit: a retrospective preliminary review and analysis of experience with the first 15 operative cases. Neurosurg Quart 9:197–208

    Google Scholar 

  7. Lee S, Suh CO, Kim GE, Yang WI, Lee SY, Hahn JS, Park JO (2002) Role of radiotherapy for primary orbital lymphoma. Am J Clin Oncol 25:261–265

    PubMed  Google Scholar 

  8. Maalouf T, Trouchaud-Michaud C, Angioi-Duprez K, George JL (1999) What has become of our idiopathic inflammatory pseudo-tumors of the orbit? Orbit 18:157–166

    PubMed  Google Scholar 

  9. Maroon JC, Kennerdell JS, Vidovich DV, Abla A, Sternau L (1994) Recurrent spheno-orbital meningiomas. J Neurosurg 80:202–208

    CAS  PubMed  Google Scholar 

  10. Mauriello JA, Flanagan JC (1990) Orbital inflammatory disease. In: Mauriello JA, Flanagan JC (eds) Management of orbital and ocular adnexal tumors and inflammations. Springer, Berlin Heidelberg New York, pp 19–46

    Google Scholar 

  11. Miller NR (2004) Primary tumours of the optic nerve and its sheath. Eye 18:1026–1037

    CAS  PubMed  Google Scholar 

  12. Nutting CM, Jenkins CD, Norton AJ, Cree I, Rose GE, Plowman PN (2002) Primary orbital lymphoma. Hematol J 3:14–16

    PubMed  Google Scholar 

  13. Schick U, Bleyen J, Hassler W (2003) Treatment of orbital schwannomas and neurofibromas. Br J Neurosurg 17:541–545

    CAS  PubMed  Google Scholar 

  14. Schick U, Bleyen J, Bani A, Hassler W (2006) Management of meningiomas en plaque of the sphenoid wing. J Neurosurg 104:208–214

    PubMed  Google Scholar 

  15. Schick U, Dott U, Hassler W (2003) Surgical treatment of orbital cavernomas. Surg Neurol 60:234–244

    PubMed  Google Scholar 

  16. Schick U, Dott U, Hassler W (2004) Surgical management of meningiomas involving the optic nerve sheath. J Neurosurg 101:951–959

    PubMed  Google Scholar 

  17. Schick U, Hassler W (2004) Neurosurgical management of orbital inflammations and infections. Acta Neurochir 146:571–580

    CAS  Google Scholar 

  18. Shields JA, Shields CL, Brotman H, Carvalho C, Perez N, Eagle RC Jr (2001) Cancer metastatic to the orbit. The 2000 Robert M. Curts Lecture. Ophthal Plast Reconstr Surg 17:346–354

    CAS  PubMed  Google Scholar 

  19. Shields CL, Shields JA, Carvalho C, Rundle O, Smith AF (2001) Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology 108:979–984

    CAS  PubMed  Google Scholar 

  20. Turbin RE, Pokorny K (2004) Diagnosis and treatment of orbital optic nerve sheath meningioma. Cancer Control 11:334–341

    PubMed  Google Scholar 

Selected Reading of Section 3.2.8

  1. Acheson JF (2004) Optic nerve disorders: role of canal and nerve sheath decompression surgery. Eye 18:1169–1174

    CAS  PubMed  Google Scholar 

  2. Albeck MJ, Skak C, Nielsen PR, Olsen KS, Børgesen SE, Gjerris F (1998) Age-dependency of resistance to cerebrospinal fluid outflow. J Neurosurg 89:275–278

    CAS  PubMed  Google Scholar 

  3. Binder DK, Horton JC, Lawton MC, McDermott MW (2004) Idiopathic intracranial hypertension. Neurosurgery 54:538–552

    PubMed  Google Scholar 

  4. Burgett RA, Purvin VA, Kawasaki A (1997) Lumboperitoneal shunting for pseudotumor cerebri. Neurology 49:734–739

    CAS  PubMed  Google Scholar 

  5. Bynke G, Zemack G, Bynke H, Romner B (2004) Ventriculoperitoneal shunting for idiopathic intracranial hypertension. Neurology 63:1314–1316

    PubMed  Google Scholar 

  6. Digre KB, Corbett JJ (2001) Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurology 7:2–67

    Google Scholar 

  7. Fishman RA (1992) Cerebrospinal fluid in diseases of the nervous system. Saunders, Philadelphia

    Google Scholar 

  8. Gideon P, Sørensen PS, Thomsen C, Ståhlberg F, Gjerris F, Henriksen O (1995) Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. Am J Neuroradiol 16:381–387

    CAS  PubMed  Google Scholar 

  9. Gjerris F (1998) Hydrocephalus and other disorders of cerebrospinal fluid circulation. In: Bogousslavsky J, Fisher M (eds) Textbook of Neurology. Butterworth & Heinemann, Boston, pp 655–674

    Google Scholar 

  10. Gjerris F (2000) Hydrocephalus in adults. In: Kay AH, Black PM (eds) Operative neurosurgery. Churchill Livingstone, London, pp 1236–1247

    Google Scholar 

  11. Gjerris F, Børgesen SE (2000) Pathophysiology of the CSF circulation. In: Crockard A, Hayward R, Hoff JT (eds) Neurosurgery – the scientific basis of clinical practice, 3rd edn. Blackwell Science, Boston, pp 147–168

    Google Scholar 

  12. Higgins JN, Cousins C, Owler BK, Sarkies N, Pickard JD (2003) Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry 74:1662–1666

    CAS  PubMed  Google Scholar 

  13. Skau M, Brennum J, Gjerris, Jensen R (2006) What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalgia 26:384–399

    CAS  Google Scholar 

  14. The International Classification of Headache Disorders (2004), 2nd edn. Cephalalgia 24 [Suppl 1]:9–160

    Google Scholar 

Selected Reading of Section 3.2.9.1

  1. Di Rocco C (1999) Cerebellar astrocytoma. In: Choux M, Di Rocco C, Hockley AD, Walker ML (eds) Pediatric neurosurgery, Churchill Livingstone, pp 427–459

    Google Scholar 

  2. Albright AL (1999) Medulloblastomas. In: Albright L, Pollack I, Adelson D (eds) Principles and practice of pediatric neurosurgery. Thieme, New York, pp 591–608

    Google Scholar 

  3. Tomita T (2001) Ependymomas. In: McLone DG (ed) Pediatric neurosurgery, 3rd edn. Saunders, Philadelphia, pp 822–834

    Google Scholar 

  4. Choux M, Lena G, Do L (1999) Brainstem tumors. In: Choux M, Di Rocco C, Hockley AD, Walker ML (eds) Pediatric neurosurgery. Churchill Livingstone, New York, pp 471–491

    Google Scholar 

Selected Reading of Section 3.2.9.2

  1. Rorke LB (1999) Pathology of brain and spinal cord tumors. In: Choux M, Di Rocco C, Hockley AD, Walker ML (eds) Pediatric neurosurgery, Churchill Livingstone, pp 395–426

    Google Scholar 

  2. Hockley AD, Sgouros S (1999) Tumors of the cerebral hemispheres. In: Choux M, Di Rocco C, Hockley AD, Walker ML (eds) Pediatric neurosurgery. Churchill Livingstone, New York, pp 493–507

    Google Scholar 

  3. Montes JL, Farmer JP (2001) Tumors of the cerebral hemispheres. In: McLone DG (ed) Pediatric neurosurgery, 3rd edn, Churchill Livingstone, New York, pp 738–750

    Google Scholar 

  4. Myseros JS, Reigel DH (2001) Intraventricular tumors. In: McLone DG (ed) Pediatric neurosurgery, 3rd edn, Churchill Livingstone, New York, pp 755–767

    Google Scholar 

  5. Caldarelli M, Pezzotta S (1999) Optic pathway and hypothalamic tumors. In: Choux M, Di Rocco C, Hockley AD, Walker ML (eds) Pediatric neurosurgery. Churchill Livingstone, London, pp 509–529

    Google Scholar 

Selected Reading of Section 3.2.9.3

  1. Di Rocco C, Iannelli A, Ceddia A (1991) Intracranial tumors of the first year of life. A cooperative survey of the 1986–1987 Education Committee of the ISPN. Childs Nerv Syst 7: 150–153

    PubMed  Google Scholar 

  2. Isaacs H Jr (2002) I. Perinatal brain tumors: a review of 250 cases. Pediatr Neurol 27(4):249–261

    PubMed  Google Scholar 

  3. Isaacs H Jr (2002) II. Perinatal brain tumors: a review of 250 cases. Pediatr Neurol 27(5):333–342

    PubMed  Google Scholar 

  4. Rickert CH, Probst-Cousin S, Gullotta F (1997) Primary intracranial neoplasms of infancy and early childhood. Childs Nerv Syst 13:507–513

    CAS  PubMed  Google Scholar 

  5. Wakai S, Arai T, Nagai M (1984) Congenital brain tumors. Surg Neurol 21:597–609

    CAS  PubMed  Google Scholar 

Selected Reading of Section 3.2.10

  1. Rampling R (2008) Central Nervous system. In: Price P, Sikora K and Illidge T in Treatment of Cancer. Arnold, London, pp 287–319

    Google Scholar 

  2. Valerie K et al. (2000) Novel molecular targets for tumour radiosensitisation. Molecular radiation biology and oncology workshop: translation of molecular mechanisms into clinical radiotherapy. Int J Cancer 90(1):51–58

    CAS  PubMed  Google Scholar 

  3. Jones B, Dale D (1999) Inclusion of molecular biotherapies with radical radiotherapy: modelling of combined modality treatment schedules. Int J Radiat Oncol Biol Physics 45(4):1025–1034

    CAS  Google Scholar 

  4. Rampling R (1998) Modern aspects of radiation therapy for glial tumours of the brain. Forum (Genova) 8:289–301

    CAS  Google Scholar 

  5. Rao R et al (2002) Safety of thrice daily hyperfractionated radiation and BCNU for high grade gliomas. Int J Radiat Oncol Biol Phys 53(2):376–384

    PubMed  Google Scholar 

  6. Chan J et al. (2002) Survival and failure patterns of high grade gliomas after three dimensional conformal therapy. J Clin Oncol 20(6):1635–1642

    PubMed  Google Scholar 

  7. Saren F et al (2002) Stereotactically guided conformal radiotherapy for progressive low grade tumours of childhood. Int J Radiat Oncol Biol Phys 53(1):43–51

    Google Scholar 

  8. Zhen W, Thompson RB, Enke CA (2002) Intensity-modulated radiotherapy (IMRT): the radiation oncologist’s perspective. Med Dosim 27(2):155–159

    PubMed  Google Scholar 

  9. Intensity Modulated Radiation Therapy Collaborative Working Group (2001) Intensity modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 51(4):880–914

    Google Scholar 

  10. Thilmann C et al (2001) Intensity modulated radiotherapy with an integrated boost to the macroscopic tumour volume in the treatment of high grade gliomas. Int J Cancer 96(6):341–349

    CAS  PubMed  Google Scholar 

  11. Suzuki M et al (2003) Feasibility study of the simultaneous integrated boost (SIB) method for malignant gliomas using intensity modulated radiotherapy. Jpn J Clin Oncol 33(6):271–277

    PubMed  Google Scholar 

  12. Weil M (2001) Stereotactic radiosurgery for brain tumors. HematoOncol Clin North Am 15(6):1017–1026

    CAS  Google Scholar 

  13. Prados M et al (2004) Phase III randomised study of radiotherapy plus procarbazine, lomustine and vincristine with or without BUdR for treatment of anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 58(4):1147–1153

    CAS  PubMed  Google Scholar 

  14. Walker MD et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333–343

    CAS  PubMed  Google Scholar 

  15. Scott CB et al (1998) Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90–06. Int J Radiat Oncol Biol Phys 40(1):51–55

    CAS  PubMed  Google Scholar 

  16. Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

    CAS  PubMed  Google Scholar 

  17. Karim A et al (2002) Randomized trial on the efficacy of radiotherapy for cerebral low grade glioma in the adult: European Organisation for Research and Treatment of Cancer study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52(2):316–324

    PubMed  Google Scholar 

  18. Karim ABMF et al (1996) A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844. Int J Radiat Oncol Biol Phys 36(3):549–556

    CAS  PubMed  Google Scholar 

  19. Shaw E et al. (2002) Prospective randomised trial of low-versus high dose radiation therapy in adults with supratentorial low grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study. J Clin Oncol 20(9):2267–2276

    CAS  PubMed  Google Scholar 

  20. Pignatti F et al (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20(8):2076–2084

    PubMed  Google Scholar 

  21. Pomery S et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415(6870):436–442

    Google Scholar 

  22. Packer R et al (1999) Treatment of children with medulloblastomas with reduced dose craniospinal radiation therapy and adjuvant chemotherapy: a Children’s Cancer Group Study. J Clin Oncol 17:2127–2136

    CAS  PubMed  Google Scholar 

  23. SIOP (2002) A prospectively randomised controlled trial of hyperfractionated versus conventionally fractionated radiotherapy in standard risk medulloblastoma – a protocol

    Google Scholar 

  24. Gaspar LE et al (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47(4):1001–1006

    CAS  PubMed  Google Scholar 

  25. Shehata M et al. (2004) Stereotactic radiosurgery of 468 brain metastases < or +2cm implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 59(1):87–93

    PubMed  Google Scholar 

  26. Mehta MP, Tremont-Lukats I (2002) Evaluation and management of brain metastases. In: ASCO 38th Annual Meeting 2002. American Society of Clinical Oncology, Orlando

    Google Scholar 

  27. Patchell R (2002) Treatment of brain metastases. In: ASCO 2002. American Society of Clinical Oncology, Orlando

    Google Scholar 

  28. Patchell R et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomised trial. JAMA 280(17):1485–1489

    CAS  PubMed  Google Scholar 

  29. Klein M et al. (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360(9343):1361–1368

    CAS  PubMed  Google Scholar 

  30. Brown P et al (2003) Effects of radiotherapy on cognitive function in patients with low grade glioma measured by the Folstein mini mental state examination. J Clin Oncol 21(13):2519–2524

    PubMed  Google Scholar 

  31. Hug E et al (2002) Proton radiotherapy in the management of pediatric base of skull tumours. Int J Radiat Oncol Biol Phys 54(2):1017–1024

    Google Scholar 

  32. Patel S et al. (2000) Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme. Neurosurgery 46(5):1123–130

    CAS  PubMed  Google Scholar 

  33. Suh J, Barnett G (1999) Brachytherapy for brain tumor. Hematol Oncol Clin N Am 13(3):635–650

    CAS  Google Scholar 

  34. Selker R et al (2002) The Brain Tumour Group NIH trial 87–01: a randomised comparison of surgery, external beam radiotherapy and carmustine versus surgery, interstitial radiotherapy boost, external beam radiotherapy and carmustine. Neurosurgery 51(2):343–357

    PubMed  Google Scholar 

  35. Barth R et al. (1999) Boron neutron capture therapy of brain tumors: an emerging therapeutic modality. Neurosurgery 44(3):433–450

    CAS  PubMed  Google Scholar 

  36. Sauerwein W, Zurlo A (2002) The EORTC boron neutron capture therapy (BNCT) group: achievements and future projects. Eur J Cancer 38 [Supp 4]:S31–S3.

    Google Scholar 

Selected Reading of Section 3.2.13

  1. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, McCormick F (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373–376

    CAS  PubMed  Google Scholar 

  2. Bjerkvig R, Read TA, Vajkoczy P, Aebischer P, Pralong W, Platt S, Melvik JE, Hagen A, Dornish M (2003) Cell therapy using encapsulated cells producing endostatin. Acta Neurochir Suppl 88:137–141

    CAS  PubMed  Google Scholar 

  3. Bogler O, Mikkelsen T (2003) Angiogenesis in glioma: molecular mechanisms and roadblocks to translation. Cancer J 9:205–213

    PubMed  Google Scholar 

  4. Bogler O, Mikkelsen T (2005) Angiogenesis and apoptosis in glioma: two arenas for promising new therapies. J Cell Biochem 96:16–24

    CAS  PubMed  Google Scholar 

  5. Chiocca EA, Broaddus WC, Gillies GT, Visted T, Lamfers ML (2004) Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic and viral therapies in neuro-oncology. J Neurooncol 69:101–117

    PubMed  Google Scholar 

  6. Conrad C, Miller CR, Ji Y, Gomez-Manzano C, Bharara S, McMurray JS, Lang FF, Wong F, Sawaya R, Yung WK, Fueyo J (2005) Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther 12:284–294

    CAS  PubMed  Google Scholar 

  7. Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Lecluse Y, van Beusechem VW, Gerritsen WR, Kirn DH, Vassal G (2003) Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. Br J Cancer 89:577–584

    CAS  PubMed  Google Scholar 

  8. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624–1636

    CAS  PubMed  Google Scholar 

  9. Goetz C, Riva P, Poepperl G, Gildehaus FJ, Hischa A, Tatsch K, Reulen HJ (2003) Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times. J Neurooncol 62:321–328

    CAS  PubMed  Google Scholar 

  10. Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E (2000) Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci USA 97:6803–6808

    CAS  PubMed  Google Scholar 

  11. Guha A, Mukherjee J (2004) Advances in the biology of astrocytomas. Curr Opin Neurol 17:655–662

    PubMed  Google Scholar 

  12. Hall WA, Rustamzadeh E, Asher AL (2003) Convection-enhanced delivery in clinical trials. Neurosurg Focus 14:e2

    PubMed  Google Scholar 

  13. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003

    CAS  PubMed  Google Scholar 

  14. Immonen A, Vapalahti M, Tyynela K, Hurskainen H, Sandmair A, Vanninen R, Langford G, Murray N, Yla-Herttuala S (2004) AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 10:967–972

    CAS  PubMed  Google Scholar 

  15. Kock H, Harris MP, Anderson SC, Machemer T, Hancock W, Sutjipto S, Wills KN, Gregory RJ, Shepard HM, Westphal M, Maneval DC (1996) Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int J Cancer 67:808–815

    CAS  PubMed  Google Scholar 

  16. Lamszus K, Kunkel P, Westphal M (2003) Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl 88:169–177

    CAS  PubMed  Google Scholar 

  17. Laske DW, Youle RJ, Oldfield EH (1997) Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3:1362–1368

    CAS  PubMed  Google Scholar 

  18. Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, Harran PG (2004) A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science 305:1471–1474

    CAS  PubMed  Google Scholar 

  19. Lou E (2004) Oncolytic viral therapy and immunotherapy of malignant brain tumors: two potential new approaches of translational research. Ann Med 36:2–8

    CAS  PubMed  Google Scholar 

  20. Menei P, Capelle L, Guyotat J, Fuentes S, Assaker R, Bataille B, Francois P, Dorwling-Carter D, Paquis P, Bauchet L, Parker F, Sabatier J, Faisant N, Benoit JP (2005) Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery 56:242–248; discussion 242–248

    Google Scholar 

  21. Morokoff AP, Novak U (2004) Targeted therapy for malignant gliomas. J Clin Neurosci 11:807–818

    PubMed  Google Scholar 

  22. Parney IF, Kunwar S, McDermott M, Berger M, Prados M, Cha S, Croteau D, Puri RK, Chang SM (2005) Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg 102:267–275

    CAS  PubMed  Google Scholar 

  23. Puri RK (1999) Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma. Toxicol Pathol 27:53–57

    CAS  PubMed  Google Scholar 

  24. Rainov NG (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11:2389–2401

    CAS  PubMed  Google Scholar 

  25. Ram Z, Culver KW, Oshiro EM, Viola JJ, DeVroom HL, Otto E, Long Z, Chiang Y, McGarrity GJ, Muul LM, Katz D, Blaese RM, Oldfield EH (1997) Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 3:1354–1361

    CAS  PubMed  Google Scholar 

  26. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489–501

    CAS  PubMed  Google Scholar 

  27. Reifenberger G, Collins VP (2004) Pathology and molecular genetics of astrocytic gliomas. J Mol Med 82:656–670

    CAS  PubMed  Google Scholar 

  28. Rich JN, Bigner DD (2004) Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3:430–446

    CAS  PubMed  Google Scholar 

  29. Sampson JH, Akabani G, Archer GE, Bigner DD, Berger MS, Friedman AH, Friedman HS, Herndon JE II, Kunwar S, Marcus S, McLendon RE, Paolino A, Penne K, Provenzale J, Quinn J, Reardon DA, Rich J, Stenzel T, Tourt-Uhlig S, Wikstrand C, Wong T, Williams R, Yuan F, Zalutsky MR, Pastan I (2003) Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. J Neurooncol 65:27–35

    PubMed  Google Scholar 

  30. Schlingensiepen R, Goldbrunner M, Szyrach MN, Stauder G, Jachimczak P, Bogdahn U, Schulmeyer F, Hau P, Schlingensiepen KH (2005) Intracerebral and intrathecal infusion of the TGF-beta2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety. Oligonucleotides 15:94–104

    CAS  PubMed  Google Scholar 

  31. Sikorski CW, Lesniak MS (2005) Immunotherapy for malignant glioma: current approaches and future directions. Neurol Res 27:703–716

    CAS  PubMed  Google Scholar 

  32. Tyminski E, Leroy S, Terada K, Finkelstein DM, Hyatt JL, Danks MK, Potter PM, Saeki Y, Chiocca EA (2005) Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan. Cancer Res 65:6850–6857

    CAS  PubMed  Google Scholar 

  33. Westphal M, Black PM (2004) Perspectives of cellular and molecular neurosurgery. J Neurooncol 70:257–271

    PubMed  Google Scholar 

  34. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neurooncology 5:79–88

    CAS  Google Scholar 

  35. Yang WQ, Senger D, Muzik H, Shi ZQ, Johnson D, Brasher PM, Rewcastle NB, Hamilton M, Rutka J, Wolff J, Wetmore C, Curran T, Lee PW, Forsyth PA (2003) Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma. Cancer Res 63:3162–3172

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuropathology, Medical Center of Pathology, Philipps-University Marburg, Baldingerstraße, 35043, Marburg, Germany

    H. D. Mennel

  2. Department of Neurosurgery, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark

    Flemming Gjerris

  3. Department of Neurosurgery, Bogenhausen Academic Teaching Hospital, Technical University of Munich, Englschalkinger Straße 77, 81925, München, Germany

    Christianto B. Lumenta, Hartmut Gumprecht & Matthias J. Krammer

  4. Neurochirurgische Klinik, Universitäts-Krankenhaus Eppendorf, Martinistraße 52, 20246, Hamburg, Germany

    Manfred Westphal

  5. Neurochirurgische Klinik, HELIOS Klinikum Berlin, Schwanebecker Chaussee 50, 13125, Berlin, Germany

    Jürgen Kiwit

  6. Department of Neurosurgery, Hôpital Lariboisière 2, rue Ambroise Paré, 75475, Paris, France

    Bernard George

  7. Neurochirurgische Klinik, Klinikum Duisburg gGmbH, Zu den Rehwiesen 9, 47055, Duisburg, Germany

    Werner-Erwin Hassler & Uta Schick

  8. Department of Pediatric Neurosurgery, Catholic University Medical School, Largo A. Gemelli 8, 00168, Rome, Italy

    Massimo Caldarelli, Gianpiero Tamburrini & Vita Ridola

  9. Istituto di Neurochirurgica, Università Cattolica del Sacro Cuore Policlinico Gemelli, Largo Gemelli 8, 00168, Rome, Italy

    Concezio Di Rocco

  10. Beatson Oncology Centre, Western Infirmary, G11 6NT, Glasgow, UK

    Roy P. Rampling

  11. Neuro-Oncology Unit, Daniel den Hoed Oncology Center, 5201, 3008 AE, Rotterdam, Netherlands

    Martin J. van den Bent

  12. Pediatric Oncology Department, Institut Gustave Roussy, Villejuif, France

    Jacques Grill

  13. Department of Neurosurgery, University of Groningen Medical Centre UMCG, 30.001, 9700 RB, Groningen, Netherlands

    Jan Jakob A. Mooij

Authors
  1. H. D. Mennel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Flemming Gjerris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christianto B. Lumenta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hartmut Gumprecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Matthias J. Krammer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Manfred Westphal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jürgen Kiwit
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bernard George
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Werner-Erwin Hassler
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Uta Schick
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Massimo Caldarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Concezio Di Rocco
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Gianpiero Tamburrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Roy P. Rampling
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Martin J. van den Bent
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Vita Ridola
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Jacques Grill
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Jan Jakob A. Mooij
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurosurgery, Bogenhausen Academic Teaching Hospital, Technical University of Munich, Englschalkinger Straße 77, 81925, München, Germany

    Christianto B. Lumenta

  2. Istituto di Neurochirurgica, Università Cattolica del Sacro Cuore Policlinico Gemelli, Largo Gemelli 8, 00168, Rome, Italy

    Concezio Di Rocco

  3. Institute of Health Science and Technology, Faculties of Engineering, Science and Medicine, Aalborg University, Fredrik Bajers vej 7 D3, 9220, Aalborg East, Denmark

    Jens Haase

  4. Department of Neurosurgery, University of Groningen Medical Centre UMCG, 30.001, 9700 RB, Groningen, Netherlands

    Jan Jakob A. Mooij

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mennel, H. et al. (2010). Brain Tumors. In: Lumenta, C., Di Rocco, C., Haase, J., Mooij, J. (eds) Neurosurgery. European Manual of Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79565-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79565-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79564-3

  • Online ISBN: 978-3-540-79565-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation